Show Notes
When US President Donald Trump threatened 200 per cent tariffs on foreign-made pharmaceuticals, investors responded like it was a placebo. It’s the latest spat between drugmakers and an administration that share a complicated relationship. The FT’s Hannah Kuchler and Patrick Temple-West explain why Trump and Big Pharma aren’t getting along, and what that prescribes for the future of the industry.
Mentioned in this podcast: Email Marc your questions ([email protected]) Investors shrug off Donald Trump’s 200% tariff on pharma The looming ‘patent cliff’ facing Big Pharma Sign up for the FT’s Swamp Notes newsletter here
Swamp Notes is produced by Henry Larson. Topher Forhecz is the FT’s executive producer. The FT’s acting co-head of audio is Topher Forhecz. Special thanks to Pierre Nicholson.
CREDIT: The White House, Roll Call
Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
More from Swamp Notes
Democrats are looking for a bit of a rebrand after losing the White House and both houses of Congress in 2024. They have an opportunity this November to test out some new types of candidates. In a critical swing district in Pennsylvania, the party establishment has coalesced around a progressive, blue-collar candidate named Bob Brooks. The other frontrunner in the race, Ryan Crosswell, represents a very different vision for winning over swing voters. He’s a former Republican and former federal prosecutor who’s more centrist.
Iran and the US more or less came to the table earlier this week. But the agreed ceasefire is already starting to show cracks. For the final episode of Swamp Notes, the FT’s Washington bureau chief explains why both sides decided to pause the fighting, and what this conflict has revealed about Donald Trump’s foreign policy.
A year ago this week, US President Donald Trump rocked the world with his so-called liberation day announcement. America’s tariff regime affected all aspects of life from the global economy to the day-to-day of average business owners. As part of a special FT News Briefing series, the FT’s US economics editor Claire Jones explains what changed, and what didn’t, because of those tariffs.
It’s hard to square US President Donald Trump’s circle. Earlier this week, he said his administration was speaking with Iranian officials. Stocks shot up, oil crashed. Then, Iran denied that talks were ongoing and the US ordered more troops to the Gulf. The FT’s foreign affairs correspondent Abigail Hauslohner and markets columnist Katie Martin explain the role markets play in why Trump’s messaging doesn’t align with his actions.
When it comes to data centres, the Trump administration has been urging AI companies to “build, baby, build”. But the White House’s agenda is facing resistance from an unlikely place: the very states that won Donald Trump the presidency.